Advertisement ยท 728 ร— 90

Posts by Rebecca Eccles

Preview
Cancer and the host Taking place on 17 - 19 June 2026 in London, UK. Registration now open.

Next week is the final week to submit abstracts for Cancer and the Host: www.cancergrandchallenges.org/conferences/...

๐Ÿ“ฅ Abstract deadline: 20 March
๐Ÿ—“๏ธ 17โ€“19 June 2026
๐Ÿ“The Royal Society, London

This conference brings together leading researchers to explore cancer as a systemic disease. Read more ๐Ÿ‘‡

1 month ago 2 1 0 0
Post image

The new @cancergrand.bsky.social teams have been announced! Read about the teams tackling cancer avoidance, mechanisms driving mutational signatures, the dark proteome, cancer neuroscience, & rewiring cancer cells now in Cancer Discovery @aacrjournals.bsky.social: aacrjournals.org/cancerdiscov...

1 month ago 4 1 0 0
Figure 2 The dimensions of cancer
CREDIT Hanahan - Cell.

Figure 2 The dimensions of cancer CREDIT Hanahan - Cell.

An update to the Hallmarks of Cancer framework for understanding (and researching) what causes human cancers. spkl.io/63321Aqwbc

Douglas Hanahan
@cp-cell.bsky.social

2 months ago 21 10 0 10
Post image Post image Post image

The October issue of Cancer Discovery @aacrjournals.bsky.social is now online! The cover features two papers on the role of #ecDNA heterogeneity in tumor evolution and adaptation to therapy - you can find these papers and much more here: aacrjournals.org/cancerdiscov...

6 months ago 5 3 1 1
Preview
Boltz-2: democratising the future of drug design Open source structure prediction with binding affinity

Move over AlphaFold3. Boltz-2 has arrived, bringing affinity prediction for protein-small molecule interactions!

Canโ€™t wait to see what this group does next. Congrats to all @gcorso.bsky.social

Was a pleasure writing this:
www.cancergrandchallenges.org/news/boltz-2...

10 months ago 37 8 1 0
Video

Excited to unveil Boltz-2, our new model capable not only of predicting structures but also binding affinities! Boltz-2 is the first AI model to approach the performance of FEP simulations while being more than 1000x faster! All open-sourced under MIT license! A threadโ€ฆ ๐Ÿค—๐Ÿš€

10 months ago 214 91 10 11
Post image Post image

Come and join us! Weโ€™re hiring a new Group Leader in Generative Biology at the @sangerinstitute.bsky.social

Building AI models or the data to train them?

Core funding of >$130M a year for a faculty of ~30.

www.nature.com/naturecareer...

acrobat.adobe.com/id/urn:aaid:...

pls RT!

11 months ago 46 66 1 0
Advertisement

Mariam is part of team CANCAN, who are tackling the @cancergrand.bsky.social cachexia challenge!

11 months ago 2 1 0 0
Post image

We're hiring! The Journal of Cell Biology (JCB) seeks Scientific Editor or Senior Scientific Editor, dependent on experience. Join our team in New York City! More info ๐Ÿ‘‰ careers.rockefeller.edu/jobs?keyword...

#STEMjobs #LifeScienceJobs #PublishingJobs #ScienceJobs

11 months ago 3 3 0 0

Hello, we are AITHYRA!
I am very excited to share with you the corporate identity of AITHYRA, the Research Institute for Biomedical AI.

Check out the brand design video (sound on!) to learn more.

**REMINDER**
One week left to apply for Starting PI positions (Life Science and AI/ML). Come join us!

11 months ago 20 8 0 0
Preview
DFS 0161 CGC Discover mag 2024 A year of scientific creativity

The 24/25 edition of @cancergrand.bsky.social progress magazine is now live!

Including:
๐Ÿ‘‰key advances from our funded teams
๐Ÿ‘‰ the biggest themes in cancer research from early-onset cancers to AI and cancer as a systemic disease
๐Ÿ‘‰our 7 new challenges

features.cancerresearchuk.org/cancergrandc...

11 months ago 9 5 0 1